PT  - JOURNAL ARTICLE
AU  - Ananda Tiwari
AU  - Anssi Lipponen
AU  - Anna-Maria Hokajärvi
AU  - Oskari Luomala
AU  - Anniina Sarekoski
AU  - Annastiina Rytkönen
AU  - Pamela Österlund
AU  - Haider Al-Hello
AU  - Aapo Juutinen
AU  - Ilkka T. Miettinen
AU  - Carita Savolainen-Kopra
AU  - Tarja Pitkänen
TI  - Detection and quantification of SARS-CoV-2 RNA in wastewater influent in relation to reported COVID-19 incidence in Finland
AID  - 10.1101/2021.10.05.21264462
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.10.05.21264462
4099  - http://medrxiv.org/content/early/2021/10/07/2021.10.05.21264462.short
4100  - http://medrxiv.org/content/early/2021/10/07/2021.10.05.21264462.full
AB  - Wastewater-based surveillance is a cost-effective concept for monitoring COVID-19 pandemics at a population level. Here, SARS-CoV-2 RNA was monitored from a total of 693 wastewater (WW) influent samples from 28 wastewater treatment plants (WWTP, N = 21–42 samples per WWTP) in Finland from August 2020 to May 2021, covering WW of ca. 3.3 million inhabitants (∼ 60% of the Finnish population). The relative quantity of SARS-CoV-2 RNA fragments in the 24h-composite samples was determined by using the ultrafiltration method followed by nucleic acid extraction and RT-qPCR assay targeted with N2-assay. SARS-CoV-2 RNA signals at each WWTP were compared over time to the numbers of new and confirmed COVID-19 cases in the sewer network area.Over the 10-month surveillance period, the detection rate of SARS-CoV-2 RNA in WW was 79% (including 6% uncertain results), while only 24% of all samples exhibited gene copy (GC) numbers above the quantification limit. The range of the SARS-CoV-2 detection rate in WW varied from 33% (including 10% uncertain results) in Pietarsaari to 100% in Espoo. Only six out of 693 WW samples were positive with SARS-COV-2 RNA when the reported COVID-19 case number from the preceding 14 days was zero. Overall, the 14-day COVID-19 incidence was 7, 18 and 36 cases within the sewer network area when the probability to detect SARS-CoV-2 RNA in wastewater samples was 50%, 75% and 95%, respectively. The quantification of SARS-CoV-2 GC required significantly more COVID-19 cases: the quantification rate was 50%, 75% and 95% when the 14-day incidence was 110, 152 and 223 COVID-19 cases, respectively, per 100 000 persons. Multiple linear regression confirmed the relationship between the COVID-19 incidence and the SARS-CoV-2 GC quantified in WW at 15 out of 28 WWTPs (overall R2 = 0.36, p < 0.001). At four of the 13 WWTPs where a significant relationship was not found, the GC of SARS-CoV-2 RNA remained below the quantification limit during the whole study period. In the five other WWTPs, the sewer coverage was less than 80% of the total population in the area and thus the COVID-19 cases may have been inhabitants from the areas not covered.Based on the results obtained, WW-based surveillance of SARS-CoV-2 could be used as an indicator for local and national COVID-19 incidence trends. Importantly, the determination of SARS-CoV-2 RNA fragments from WW is a powerful and non-invasive public health surveillance measure, independent of possible changes in the clinical testing strategies or in the willingness of individuals to be tested for COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Finnish Government supplementary budget for COVID-19 research; the Ministry of Agriculture and Forestry [grant number 4400T-0807]; and the Academy of Finland [grant number 339415].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Finnish Institute for Health and WelfareI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis work is part of that carried out by the national COVID-19 task force at the Finnish Institute for Health and Welfare (THL). The wastewater-based surveillance results of SARS-CoV-2 in comparison to detected COVID-19 cases in the sewer network areas and the wastewater data is publicly available [In Finnish]. Further, the numbers of confirmed new COVID-19 cases reported in each municipality of Finland are publicly available. https://www.thl.fi/episeuranta/jatevesi/jatevesiseuranta_viikkoraportti.html https://thl.fi/en/web/thlfi-en/research-and-development/research-and-projects/sars-cov-2-at-wastewater-treatment-plants/coronavirus-wastewater-monitoring https://thl.fi/coronamap https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/situation-update-on-coronavirus/map-application-on-corona-cases